Olmesartan Medoxomil And Hydrochlorothiazide Tablet
Product Images NDC 70756-812

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 70756-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olme Hctz 01

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets, strength 20 mg/12.5 mg, 30 tablets per container. Manufactured by Umedica Laboratories Pvt. Ltd., India, and labeled by Lifestar Pharma LLC, Mahwah, NJ. Includes storage instructions, a caution to keep out of reach of children, and branding with the Lifestar logo.*

FDA Label Image

Olme Hctz 02

Packaging label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/12.5 mg, oral tablets. The label includes 90 tablets per container and is manufactured for Lifestar Pharma LLC. Storage instructions and warnings are printed, along with manufacturer details from Umodica Laboratories Pvt. Ltd., India. The label features barcodes and regulatory information.*

FDA Label Image

Olme Hctz 03

Label for Olmesartan Medoxomil and Hydrochlorothiazide tablets, strength 40 mg/25 mg, oral tablets. The label indicates packaging of 1000 tablets, manufactured by Umedica Laboratories Pvt. Ltd., India, and labeled for Lifestar Pharma LLC. The label includes storage instructions and a warning to keep out of reach of children.*

FDA Label Image

Olme-hctz-structure-1 (Olme Hctz Structure 1)

Chemical structure of the active ingredient Olmesartan Medoxomil, showing detailed atomic connections and molecular framework.*

FDA Label Image

Olme-hctz-structure-2 (Olme Hctz Structure 2)

Chemical structure of the active ingredient Olmesartan Medoxomil and Hydrochlorothiazide, showing the molecular configuration as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.